KCNA3 and type 1 diabetes mellitus: ShK, a sea anemone peptide that potently and selectively blocks Kv1.3, was shown to be effective in six animal models of autoimmune disease: MS, T1D, rheumatoid arthritis, allergic contact dermatitis, bone resorption and delayed type hypersensitivity [9].